LAUSR

Tisotumab vedotin; First FDA Approved Antibody-drug Conjugate for Cervical Cancer.

Sign Up to like & get
recommendations!
0 Published in 2022 at "Anti-cancer agents in medicinal chemistry"

DOI: 10.2174/1871520622666220421095240

Abstract: read more here.

Keywords: cancer; approved antibody; vedotin first; tisotumab vedotin ... See more keywords